Zymeworks Inc. (ZYME) is a publicly traded Healthcare sector company. As of October 15, 2026, ZYME trades at $24.76 with a market cap of $1.80B and a P/E ratio of -13.16. ZYME moved -0.06% today. Year to date, ZYME is -6.95%; over the trailing twelve months it is +35.87%. Its 52-week range spans $9.03 to $31.34. Analyst consensus is strong buy with an average price target of $40.83. Rallies surfaces ZYME's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
13 analysts cover ZYME: 0 strong buy, 13 buy, 0 hold, 0 sell, and 0 strong sell. The consensus rating is strong buy. The average price target is $40.83.
| Metric | Value |
|---|---|
| Price | $24.76 |
| Market Cap | $1.80B |
| P/E Ratio | -13.16 |
| EPS | $-2.02 |
| Dividend Yield | 0.00% |
| 52-Week High | $31.34 |
| 52-Week Low | $9.03 |
| Volume | 4 |
| Avg Volume | 0 |
| Revenue (TTM) | $37.13M |
| Net Income | $-149.99M |
| Gross Margin | 0.00% |
13 analysts cover ZYME: 0 strong buy, 13 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $40.83.